Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 1Phase 2 1

Status

Completed 4Unknown 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 2Head & Neck 1

Conditions

Breast Neoplasms 2Stage I or II Micro-invasive Oral Cancer 1Head and Neck Neoplasms 1Dermatitis 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Reference Standards × Clear all
NCT04603911 2025-01-10

RCT Comparing ESPB Solutions in Breast Surgery

Tufts Medical Center

Phase 2 Completed
75 enrolled
Breast

Breast Neoplasms

NCT05982197 2023-08-08

Curcumin Gel On Radiation Induced Oral Mucositis

University of Baghdad

Phase NA Completed
40 enrolled
Head & Neck

Head and Neck Neoplasms

NCT05417529 2022-06-14

PMLOS

Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari

Phase NA Completed
60 enrolled

Stage I or II Micro-invasive Oral Cancer

NCT01762020 2017-03-08

Barrier Film vs. Standard Skin Care in Preventing Dermatitis in Women With Breast Cancer Receiving Radiation

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 3 Completed
56 enrolled
Breast

Breast Neoplasms, Dermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡